Akebia Therapeutics to Present at the 36th Annual Piper Sandler Healthcare Conference

CAMBRIDGE, Mass., Nov. 25, 2024 /PRNewswire/ -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John Butler, Chief Executive Officer, will participate in a Fireside Discussion at the 36th Annual Piper Sandler Healthcare Conference on Tuesday, December 3rd at 10:30 AM EST.A webcast of the presentation can be accessed through the "Investors" section of Akebia's website at https://ir.akebia.co ...